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FROM THE EDITOR
Hips and Knees
Pennsylvania has done it again!  With modest fanfare, the Pennsylvania Health Care Cost
Containment Council (PHC4), an independent state agency charged with collecting, analyzing
and reporting information (that can be used to make more informed decisions thereby improving
the quality and restraining the cost of health care in Pennsylvania), has released the first ever
publicly funded, statewide physician- and hospital-specific report on the outcomes of total hip and
knee replacement surgery.  If nothing else, this report is a tour de force of our data collection and
dissemination capabilities.  What does this report contain and what are its implications?  What’s
missing and, as a result, what might be the final impact of said report?
The official report entitled, “Total Hip and Knee Replacements” for the Fiscal Year July 1,
2001 to June 30, 2002, was released earlier this past summer.1 There are several key findings in
this important report including the fact that total hip and knee replacements have steadily increased
in Pennsylvania.  Most notably, between 1993 and 2002 the number of knee replacements
increased by more than 70 percent and the number of total hip replacements increased by nearly
50 percent.  With this dramatic increase in surgery comes some untoward consequences including
a readmission rate due to deep joint infection or device problems that resulted in nearly $30
million in charges and more than 6,000 hospital days.  
The report outlines, by individual hospital and surgeon, the total number of cases in Pennsylvania
at a staggering 29,710 with 9,769 total hip cases and 19,941 total knee cases.  In a press release
accompanying the report, Marc P. Volavka, the executive director of PHC4 noted, “This report
demonstrates that most hospitals and orthopaedic surgeons in Pennsylvania are providing good to
excellent care overall.  However, variation in readmissions due to complications and infections
continued to present major opportunities for quality improvement and cost containment.”1
Putting the hip and knee report into national perspective is a complex issue.  Astute readers of
the Health Policy Newsletter know that we have covered aspects of this territory previously in
“Heart Attacks in Pennsylvania” (September 1996), “Report on Report Cards” (May 1998), and
most recently, “The Vision for a National Quality Report” (September 2001).  Space precludes
my ability to review the literature on the impact of public reporting.  One thing is for sure,
Pennsylvania has made a unique contribution to the national conversation about accountability
and outcomes in health care.  Pennsylvanians now have an opportunity to ask far more detailed
questions of their prospective orthopaedic physician including issues such as: “What is your deep
joint infection or device problem rate?; How many blood clots in the lung or leg did your patients
have in the last year?; and, “What is the likelihood of my being readmitted to the hospital under
your care?”  We are now able to engage in a conversation with these provocative questions in a
way that simply did not previously exist.
Yet, as in my previous columns on report cards and performance reports in medicine, I remain
ambivalent about the overall impact of this report and its predecessor reports on coronary artery
bypass graft surgery.  Here’s why.  The literature on the public’s ability to analyze this information
certainly presents a rather dim view.  Experts like Judith Hibbard from the University of Oregon
in Eugene, and others, have been writing for nearly a decade about what the public really wants in
a report card.2 In a nutshell, the public has a difficult time discerning issues such as lower than
expected or higher than expected rates of complications, readmission, or post-operative length of
stay.  It turns out, the public is interested, probably, in “Where will I be safer?” and “What is the
likelihood of harm?”  These are notoriously difficult issues to quantify.  Also, we know that the
public still, regrettably, chooses physicians largely based on the advice of family and friends
without much regard to an internalization of the results of multiple public report cards available
now online 24 hours a day.3
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There is another dark side to public reporting that has recently
come to light.  Some national experts contend that there are
“unintended consequences of public reporting including causing
physicians to avoid sick patients in an attempt to improve their
quality ranking, encouraging physicians to achieve target rates
for health care interventions even when it may be inappropriate
among some patients, and discounting patient preferences in
clinical judgment.4 Public reporting of quality information
promotes a spirit of openness that may be valuable for
enhancing trust of the health professions, but its ability to
improve health remains undemonstrated and public reporting
may inadvertently reduce rather than improve quality.”
The controversy surrounding the value of detailed public
accountability for health care services remains unresolved.
What else, then, is missing from this important new report?  Of
course, the report does not give us patient-specific information
about their ability to return to productive work and to enjoy a
renewed quality of life.  Physician-specific reports on deep joint
infection and blood clots are important as they may lead to work
to improve the process of care.  But, the report is only a jumping
off point, a moment in time.  It does not provide us, like all
public reports, with a roadmap for improvement.  
Some time ago, Marvin Bentley and I carefully studied the
impact of public reporting for coronary artery bypass graft
surgery in Pennsylvania.5 We found that, while individual
referring physicians, patients, and managed care organizations
may have given scant attention to CABG report cards, it was the
hospitals who took the reports to heart and used them as quality
filters to more carefully examine their own processes and
systems of care.  The fact remains, however, that as the data in
the hip and knee report diffuses rapidly into the marketplace, we
may regrettably see orthopaedic surgeons more carefully pre-
selecting patients, turning away those who are obese with severe
diabetes or with a history of multiple chronic medical problems.6
Is all lost, then, in the seeming morass of public accountability
and our inability to effectively use the information?  I think not!
PHC4 has made, in my opinion, a major contribution to our
understanding of the processes involved in providing such
complex surgery as hip and knee replacement.  The report has
given hospitals a wake-up call to carefully self-evaluate and seek
ways to improve the quality and safety of medical care.  The
report has given individual physicians ample reason to look in
the mirror and ask difficult questions about their own
performance.  Careful readers of the report will note that some
physicians do a handful of hip and knee cases on an annual
basis, while others do more than 340!  I know which doctor I
would prefer to go to, and it’s no secret that most referring
physicians would want a high-volume surgeon operating on
them or a family member.  As we move to a world of consumer
directed health plans, the Pennsylvania report might come in
very handy for individuals as they navigate the complex waters
of hospital and physician selection.
I will go one step further.  I challenge every other state to
organize and disseminate a comparable report so that we can
create a national benchmark regarding total hip and knee
replacement surgery.  In addition, I challenge the Center for
Medicare and Medicaid Services to publicly endorse this report
and begin a national dialogue regarding the possibility of linking
outcomes to the payment process for total hip and knee
replacement.  Finally, I would urge every major employer in
Pennsylvania to carefully study this report.  As I noted in the
Philadelphia Inquirer story that accompanied the debut of this
report, “There is not a single doctor or hospital in the state
whose performance is exemplary across all of the measures nor
is there a single doctor or hospital whose performance is
unacceptable.7 This report is only the beginning of the hard
work necessary to improve the quality of hip and knee
replacement surgery in the Commonwealth.”  I am proud of 
our department’s involvement in this work through my service
as the chairman of the Technical Advisory Group of the PHC4.
The report has made us all take a long look in the mirror.  The
question remains, are we happy with the images that we see?  
As usual I am interested in your views, and you may contact me
at my e-mail address, which is david.nash@jefferson.edu.
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Letters to the Editor
Please note:  The comments expressed by the authors in this publication do not necessarily represent the views of the Editorial Board, 
Thomas Jefferson University, Jefferson Medical College, Jefferson Health System or of the Department of Health Policy.
David, 
Even though we all have too much to do and read, each
time I receive the Health Policy Newsletter I keep it in my
briefcase until a moment arises, then read at the very least
your editor's piece. It is always insightful, forward looking
and interesting. The June 2005 editorial, “Trilogy of Woe”
was one of the best! Thanks for keeping us well versed in
these important topics.
Mark Linzer MD
Professor and Chief
Section of General Internal Medicine
University of Wisconsin School of Medicine
David, 
I read your “Trilogy of Woe” editor’s comment in the 
June 2005 Health Policy Newsletter.  It commented on three
books: 1) Critical Conditions: How Health Care in America
Become Big Business and Bad Medicine, 2) On the Take:
How Medicine’s Complicity With Big Business Can
Endanger Your Health, and 3) The Truth About the Drug
Companies: How They Deceive Us and What to Do 
About It.  
Your remarks were on point.  
A few years back, I had the honor of being asked to
provide ongoing expert counsel over the course of a couple
of years to a federal court judge in one of the nation’s most
high profile school desegregation cases.  During one of our
many meetings, I asked the judge how he was able to come
to decisions in cases such as this when, in my view, all sides
in the dispute advocated only for funding of their own
narrow self-interest without regard for, or sufficient financial
analysis of, the impact of such rulings on the entire system.
He said it didn’t always work, but that simply investigating
the inequities in a system sometimes was sufficient to
reduce them.
We all know examples of “legalized corruption” and
harmful secrecy in the U.S. healthcare delivery system 
today that create waste and increase suffering.  Similarly, 
we all recognize that healthcare budgets are under fire due
to the impact of an increasingly conservative public policy
view whose leaders suggests that the less fortunate should
fend for themselves – even in basic health care services.  
It may be that in the U.S. healthcare debate, there is no
middle ground, and that each special interest will continue
to pursue their narrow funding concerns indefinitely without 
regard for the sustainability of the system as a whole.  
Moreover, it may be that the rest of the modern world is
right in their conclusion that the only workable solution lies
in some form of global budgeting for healthcare delivery.  
Whatever system we use to fund health care in the U.S.
must have three characteristics in order to work: 
1) Rich and poor citizens alike must recognize that
they will share use of the same healthcare delivery system.
A sense of shared destiny will ensure adoption of a more
equitable and more thoughtful healthcare policy.  
2) Healthcare delivery system quality and cost must
become more transparent.  Removing the veil of secrecy that
surrounds healthcare delivery will highlight delivery system
inequities thereby impeding the growth of separate and
unequal delivery systems for the rich and poor classes. 
3) Government’s healthcare funding mechanisms must be
honest, and must not rely on debt or budgeting gimmicks
that disguise debt.  U.S. debt growth, if it remains unbridled,
will bind our children’s and grandchildren’s future to the
whims of the world’s current lender nations such as Saudi
Arabia and China, and may make peace less likely.  
Through debt, all things are possible – except a bright
future.
Warm regards,
Bruce A. Boissonnault
President
Niagara Health Quality Coalition 
Dr. Nash,
Thanks for continuing to send me your Health Policy
Newsletter. I always find the articles interesting as they
apply to the improving quality in health care. The article
concerning health literacy does support the idea that all of
the quality initiatives will not be effective unless the patient
can understand what to do. If I was leading a project to
improve health literacy, I would find six people who have 
to communicate with the marginally literate daily and form 
a team with the objective of developing effective
communication techniques for these marginally literate
patients. The key to this project is finding the right six
people who work daily under difficult conditions in trying 
to communicate with the marginally literate.
Bob Marquis
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Stroke, traumatic brain injury (TBI), and 
a variety of other diseases and injuries can
impair cognitive function, with resulting
impacts on personal, social, and vocational
realms. Indeed, it is the cognitive and
behavioral results of these central nervous
system (CNS) insults that lead to the most
serious long-term disability. Despite the fact
that cognitive impairments are common and
disabling, and that those who suffer from them
are frequently the recipients of inpatient and
outpatient rehabilitation services, current practice of cognitive
rehabilitation rests on a very sparse evidence base.
There are several reasons for the paucity of rigorous 
efficacy research in cognitive rehabilitation. Only controlled
research can sort out the impact of treatment from ongoing
spontaneous recovery and natural learning processes. Yet 
this research is extremely complex and costly to undertake.
Whereas pharmacological treatment trials can often be
embedded in an ongoing treatment process that is paid for by
clinical dollars, experimental treatments delivered by therapists
in a teaching/learning context are much more costly. A recent
example studied in a multicenter trial was partial body weight
supported treadmill training to improve ambulation in spinal
cord injury, as compared to “usual physical therapy”.  It is also
much more challenging to define the active ingredients of an
interactive therapy provided by a clinician, than a drug or
surgical procedure, and to determine the most appropriate
control or comparison condition. Research is further complicated
in this area by remaining controversies about the structure and
neural control of normal cognitive processes, as well as the most
appropriate methods for measuring those processes. Finally,
there is the matter of assembling a sufficient number of patients
with similar cognitive characteristics.
In the absence of rigorous evidence on the efficacy and 
cost-effectiveness of cognitive rehabilitation interventions, 
such as various approaches to speech and language therapy
stroke-related aphasia, current healthcare financing mechanisms
are typically reluctant to pay for these services. However, the
financial and emotional toll of cognitive impairments is
enormous. The absence of firm efficacy data is not, of course,
evidence of the ineffectiveness of cognitive rehabilitation. Thus,
at present, there may be many individuals who could benefit
from cognitive rehabilitation services who are denied them
because of the current state of the evidence. Only a sustained
program of research in this area, informed by recent
developments in cognitive neuroscience, can effectively
surmount the obstacles noted above.
Researchers at Moss Rehabilitation Research Institute
(MRRI), in collaboration with colleagues at a number of other
institutions, are working to advance the state of research in this
area, in the hopes of identifying specific cognitive rehabilitation
techniques that can have a meaningful impact of real-world
function. Among these efforts is the Northeast Cognitive
Rehabilitation Research Network (NCRRN),
funded by a grant from the National
Institutes of Health (NCMRR/NICHD), to
serve as a center of excellence for research of
this type.  With this and other support, MRRI
investigators have developed a consent-based
patient registry of individuals with stroke and
TBI who are interested in participating in
studies on cognition. This registry can be
searched for individuals with specific clinical
characteristics who might be appropriate for
individual studies. A description of this registry, and its utility in
large-scale programmatic research, has been published as a
model for others to adopt.1 MRRI investigators along with their
external colleagues, have collaborative investigations underway
related to attention, language, praxis (the ability to plan and
execute skilled movements) and action planning, and executive
function (a set of overarching functions that modulate lower
level cognitive functions in the service of behavioral goals). 
These studies range from basic cognitive neuroscience
research, seeking to better define the normal cognitive process 
or how it is disrupted by disease or injury, to applied treatment
studies that seek to improve cognitive function through drug
treatment, retraining methods, or the provision of assistive
technologies. This program of research has led to the
development and publication of new assessment tools, including
the Moss Attention Rating Scale, the Naturalistic Action Test,
and quantitative methods for understanding the state of
consciousness in vegetative and minimally conscious brain
injured patients. It has also led to new therapeutic approaches 
for TBI-related attention deficits, through medication treatment,
and language deficits, through the use of computer-supported
treatment and compensation methods. Many of the outcomes 
of this research program are disseminated through the project
website www.ncrrn.org. A grant to build further infrastructure 
to support cognitive rehabilitation research is currently under
review. If funded, it will allow MRRI investigators and their
colleagues to provide additional training and support to outside
investigators conducting cognitive rehabilitation studies.
Veteran’s Administration National Center for Patient Safety Comes to Philadelphia
JOHN WHYTE, MD, PHD 
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The Department of Health Policy hosted a Professional Collaboration Day on June 14, 2005.  The following is a summary 
of the morning session, hosted by GE Healthcare, which focused on Demonstrating the Value of Data Warehouses. 
Two speakers offered their perspectives on the value of data
collected via electronic medical records (EMRs) and managed
through data warehouses.  Both speakers conduct outcomes
research using an office-based patient and data management 
EMR product designed by General Electric (GE) with the ability 
to interface with their laboratory and imaging systems.
Approximately 5,000 providers (treating over 5 million patients)
make up the GE Medical Quality Improvement Consortium
(MQIC); whose data feed into the  Centricity Data Warehouse. The
comprehensiveness of the data coupled with the volume of patients
with specific diagnoses adds power to most data analyses.
Diana Brixner, RPh, PhD is Associate Professor and Chair of
the Pharmacy Practice Department in the College of Pharmacy at
University of Utah.  She also serves as Executive Director of the
Phamacotherapy Outcomes Research Center. 
Dr. Brixner introduced the topic by stressing the importance of
EMR in outcomes research. She pointed out that although data is
abundant, there are barriers that impede its translation into practical
knowledge.  Information may not be easily accessible by outcomes
researchers and is often incomplete or unavailable at the time of
decision making.  
The array of available data sources includes randomized control
trials (RCTs), multi-site RCTs, patient-reported outcomes, observa-
tional studies, EMRs, public health data sources, and retrospective
claims and pharmacy data. Each type of collection method and design
has benefits and drawbacks, but EMRs have a unique advantage in
that they facilitate real-time collection and analysis of data from
real-world settings.  For instance, an EMR is updated daily with
clinical and laboratory data necessary for diagnosis and treatment,
whereas a traditional claims data source contains limited subsets of
clinical and laboratory data and has an update lag time of 3-6 months.
EMRs are clinically rich and provide longitudinal data for each
patient.  They can be shared and/or merged with other data sources
to create even richer repositories of data.  But EMRs’ promise of
improved quality of care and better information for outcomes
studies comes with a price tag.  It also comes with a set of
unresolved problems – legal issues (HIPAA compliance), provider
resistance, and interoperability between platforms among them.
Among the studies conducted by Dr. Brixner’s team at the
Pharmacotherapy Outcomes Research Center (PORC) in Salt Lake
City, UT, was Evaluation of Impact of Second Generation of
Antipsychotics (SGAs) Treatment of Weight Gain in Primary Care.
(presented at 2005 ADA meeting in San Diego).  Using Centricity
Data Warehouse data, over 50,000 patients met initial inclusion
criteria of having a prescription for any of the antipsychotic drugs
being studied, of which 9,000 were included in the final analysis.
These patients had at least one body mass index (BMI)
measurement in their EMR. Analyses demonstrated several of the
SGAs were significantly more likely to cause weight gain than
conventional antipsychotic drugs. 
James M. Gill, MD, MPH is a member of the Family and
Community Medicine Department at Christiana Care Health
System, and is affiliated with the Family Medicine and Health
Policy Departments at Jefferson Medical College. 
In addition to being an advocate of HIT (healthcare information
technology), Dr. Gill is a primary care physician who exemplifies
the benefits of implementing an EMR in the clinical setting.  Dr.
Gill echoed Dr. Brixner’s praise for Centricity/MQIC, emphasizing
the volume of records, the increased acceptance and use by
physicians, and the powerful capability to facilitate improvement 
in clinical care.  
Dr. Gill described several unfunded EMR studies he and his
colleagues have conducted, noting that EMR makes outcomes studies
relatively inexpensive to perform. For example, a simple study on the
Quality of Care for Osteoporosis in Primary Care was conducted
using Centricity data from two family practice offices and three OB/
GYN offices. The researchers looked at prescriptions for appropriate
osteoporosis-related medications and documentation of bone mineral
density (BMD) testing. Findings indicated that physicians were not
following guidelines for prevention and treatment of osteoporosis.
This gave rise to quality improvement interventions, including
provider education and a reminder system built into the EMR.
There is always room for improvement, and Dr. Gill noted that
improving the system’s ability to capture more demographic
variables for both the patient (race/ethnicity) and the provider
(specialty) would permit even greater depth in outcomes research,
particularly in the area of reducing disparities.  
Because physicians who are willing and financially able to
incorporate EMR into their practices may differ significantly from
those who are not, the findings from studies using such data
warehouses may be limited in their generalizeability.   The value of
data warehouses will increase as office-based EMR use becomes
more widespread.    
For more information about Centricity Clinical Information
Systems, please visit: www.gehealthcare.com/usen/cis/index.html
Demonstrating the Value of Data Warehouses
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Is There Long-term Value in Disease Management Programs? 
Reflection on the 2004 CBO Report
Paul Wallace, MD
Executive Director, Care Management Institute, Kaiser Permanente
In 2004, the Congressional Budget Office (CBO) was charged
with assessing whether disease management programs could “pay
for themselves.” The CBO concluded, “There is insufficient
evidence to conclude that disease management programs can
generally reduce overall health spending,” but also noted “such
programs could be worthwhile even if they did not reduce costs.”1
How does one define the value of disease management
programs? The answer will vary from stakeholder to stakeholder.
“Value” is relative and subjective. Purchasers may define value by
disease management’s affordability, consumers by the care
experience, and clinicians by the clinical quality; all will assess
programs in terms of return on investment and cost-effectiveness. 
Will disease management’s goal of “mass customization” be met
with a return on investment? Increasing numbers of consumers are
diagnosed with chronic conditions, and simply “harvesting” the
returns may lead to price relief or shareholder return in the short 
run. But only with the re-investment of these savings can disease
management companies and each stakeholder group reap the
rewards and recognize the “value” of these programs.  
Is there long-term value in disease management programs?
“Unequivocally: Yes.”
The Impact of Information Technology on Disease Management
Jeremy Nobel, MD, MPH
Faculty, Department of Health Policy and Management
Harvard School of Public Health
Information technology (IT) has a major role to play not only in
health care, but in disease management (DM). Traditional DM programs
have created communication “silos,” preventing optimal integration
of care across stakeholders - DM companies, providers, payers, and
consumers. Existing DM programs are faced with other barriers to
delivering services, including standardized care vs. customized care
(mass customization), person-to-person connectivity without IT
(distance and time factors), and the high tech vs. high touch conflict.
Emerging healthcare IT has already begun to erode existing barriers
and promote improved quality of care through such means as Web-
based personal health records (PHR), home-based biometric devices
(e.g., blood pressure cuffs that can send results directly to the PHR or
the provider’s electronic medical record system), and constant (24/7)
connectivity to the care team.  These advances promise to improve
the exchange of key health information between patients, DM organ-
izations, and providers. They can identify intervention opportunities
that may have been missed without “real-time” feedback and
communication. In the evolving world of healthcare consumerism,
these technologies encourage more involvement by patients in their care.
Most Web-based health IT companies recognize that seamless
transition to these tools and services has not and will not occur.  
Factors that may impede full implementation include consumer
receptivity, interoperability of various data sources, provider
adoption and utilization, and return on investment. Yet, there is 
great optimism that IT can flourish in health care and further DM’s
quest for improved health outcomes. 
Disease Management National Policy Issues
Christobel E. Selecky
President, Disease Management Association of America
Chief Executive Officer, Lifemasters
Many policy issues impact the implementation of disease manage-
ment (DM) within the current healthcare system. Cost concerns,
demographic factors, societal changes and delivery systems, are key
obstacles for all involved. Of particular interest to the DM industry
is the underuse of evidence-based therapies for chronic conditions. 
The major goals of DM are to close the gaps in access to chronic
care and to support the control of rising healthcare costs associated
with those chronic diseases. The Disease Management Association
of America proposes to achieve this by introducing individual
interventions at a population level through the use of evidence-
based care plans and continuous patient monitoring. 
Looking ahead, the DM industry must confront the challenge of
using DM as a platform to reduce underuse or misuse of medical
services, and address the issue of how DM can work in a consumer-
directed healthcare system. The mandate is clear - to avoid the fate
of previous medical management efforts by ensuring that, “when
we grow, we grow responsibly.”
The 2005 Disease Management Colloquium was held at Jefferson Medical College in Philadelphia on June 21-24, 2005.
The Colloquium’s goal is to better educate government agencies, the healthcare industry, employers, and the general public 
about the important role disease management programs play in improving healthcare quality and outcomes for persons 
subject to chronic conditions. The following are highlights from a number of the morning keynote presentations.
The 2005 Disease Management Colloquium a Success
1. CBO. An Analysis of the Literature on Disease Management 
Programs. October 13, 2004. Available at: www.cbo.gov/showdoc
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Chronic health conditions are the major causes
of illness, disability and death in the United
States, with African Americans bearing a greater
burden compared to Whites. In Philadelphia, this
disparity is particularly evident. According to
research conducted by the Philadelphia Health
Management Corporation (PHMC) in 2004, older
African Americans in Philadelphia were more
likely than Whites to rate their health as fair or
poor (47.5% versus 34.1%); have a chronic health condition (43.4%
versus 38.6%); have diabetes (30.5% versus 13.1%) and high blood
pressure (71% versus 51.6%).1 While recent research shows that
with appropriate training and support, persons with chronic disease
can learn to effectively manage their own diseases, few studies have
focused on what works best with underserved populations.2,3
One successful program, the Chronic Disease Self-Management
Program (CDSMP), a patient education program developed by 
Dr. Kate Lorig at the Stanford Patient Education Research Center,
has been found to improve health status and self-efficacy, and
reduce healthcare utilization in White, middle income elders using
randomized trials.4 Philadelphia’s Harvest Health project is one of
13, three-year projects funded in 2003 by the U.S. Administration
on Aging Evidence-based Disease Prevention Program.5 Harvest
Health aims to extend the CDSMP to an urban, African American,
older adult population through a collaborative efforts of four
organizations: 1) The Philadelphia Corporation for Aging, functioning
as the project administrators; 2) Center in the Park, an urban senior
center, responsible for recruiting participants and implementing the
CDSMP with 500 African American older adults; 3) Albert Einstein
Healthcare Network (AEHN), a healthcare organization, charged
with educating and seeking referrals from primary physicians; and
4) The Center for Applied Research on Aging and Health (CARAH)
at Thomas Jefferson University, which is evaluating both the
program’s effectiveness and the collaborative process.  
The CDSMP, a 6-week, 15-hour, peer-led education program is
based on the premise that people with different chronic conditions
present common issues and needs—dealing with symptoms, complex
medication regimens, behavioral lifestyle adjustments and obtaining
helpful medical care. The program is designed to empower patients
to assume an active role in their health by managing symptoms. .
The mechanisms that underlie the program’s effectiveness include:
1) participant development of weekly action plans based on indi-
vidualized goals, 2) instruction in multiple approaches to symptom
management, and 3) group dynamics that provide opportunities for
problem solving, peer modeling, and social persuasion.  
A key issue in translating evidence-based programs to community
groups is balancing intervention fidelity (i.e. is the program being
delivered as it is intended) with program modifications deemed
necessary to ensure acceptance by the target population and
community.6,7 Harvest Health replicates the essential elements of
CDSMP, but also implements cultural modifications to maximize
the program’s acceptability.  One important adaptation was the
name choice, “Harvest Health”. Developed by Center in the Park,
the partners endorsed this name based upon the historical and
biblical associations many African Americans have with the word
“harvest”.  The program’s name is a welcoming and warm, non-
medical symbol signifying the concept that one reaps what one
sows (e.g., taking care of yourself results in an abundance of health). 
As of July 1, 2005, 322 persons (mean age 
of 72 years, 78 percent female) have participated 
in Harvest Health, with a retention rate of 87
percent (those attending at least 4 of 6 weekly
classes). Preliminary results indicate a high level
of satisfaction among participants. Through a
pre- and post-intervention evaluation design, Year
One outcomes for the 94 participants who
completed both a baseline and a 4-month
follow-up questionnaire indicate significant increases in stretching
and strengthening activities (p=.000), a trend towards increases in
aerobic physical activity (p=.076), and a significant reduction in health
distress (p=.000).  At 4 months, 95 percent reported continued use
of strategies to increase physical activity, improve their diet, and
increase symptom management.
The project’s collaborative process evaluation includes both
quantitative and qualitative measures using periodic surveys and
structured interviews of each team member to identify the
mechanisms by which the partnering organizations can work
together more successfully, as well as barriers that may impede
effective teamwork.  Key factors for trust-building and cohesive
partnerships have been the establishment and refinement of systems
for ongoing communication, providing strong project leadership,
and creating a safe environment to voice opinions.  These data
highlight the importance of each organization’s having an ongoing
commitment to the project goals, and developing processes for
continually assessing and negotiating each partner’s role.  
The Harvest Health project thus far demonstrates the utility of 
the CDSMP patient self-management program with a traditionally
underserved population, African American older adults.  It also
shows the value and importance of partnerships to ensure the
success of translating and implementing evidence-based programs
to enhance the health of a targeted community. This collaborative
approach, linking community service organizations with healthcare
organizations, is an important, replicable model that can be used in
the implementation of additional evidence-based programs (e.g., 
fall prevention) with other target populations. 
Harvest Health: Chronic Disease Self-Management Program
for Older African-Americans
NANCY L. CHERNETT, MA, MPH 
AND LAURA N. GITLIN, PHD
CENTER FOR APPLIED RESEARCH
ON AGING AND HEALTH, 
THOMAS JEFFERSON UNIVERSITY
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CENTER IN THE PARK AND ALBERT EINSTEIN
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Dr. Jacques Chaoulli, a Montreal general
practitioner, has cracked open Canada’s
prohibition of private payment for services
covered by the nation’s 30-year-old single
payer healthcare delivery system.
On behalf of a patient who had learned that
it would take a year or more to replace his
painful, arthritic hip, Dr. Chaoulli challenged
the nation’s Supreme Court, which, in a 4-3 ruling, decided,
“Access to a waiting list is not access to health care.”
In a press briefing in Washington, Dr Chaoulli, who had taken
courses in law to prepare for his unique and quixotic battle, said
that the ruling is like the fall of a second Berlin Wall… and that
the other nine provinces will also likely make way for a private
stratum of healthcare insurance.
Asked how his physician colleagues felt about his quest, 
Dr Chaoulli said that the Canadian Medical Association (CMA)
was at first skeptical, but once the Supreme Court’s ruling came
down, CMA president Dr. Albert Schumacher called it a historic
one that could change the foundations of Medicare. Dr Chaoulli
added that individual physicians’ reactions were twofold. Those
who had known no other form of healthcare delivery “could be
scared by my victory because it might introduce competition 
and performance assessment.” A second group is more open to
entrepreneurial solutions to a system that, Chaoulli averred, has
no one leading its evolution. The CMA is
basically a union monopoly, he said, and the
single payer system came about in part due 
to union pressure.
“I saw patients suffering and dying,” 
he said and nobody was talking about the
infringement of their rights. “After Chaoulli,”
he said, the doors are open to a stratum of
care that will run parallel to a “compulsory, socialized program.”
He warned that those who urge a single payer system in the
United States should be aware that it would inevitably lead to
lengthy waiting lists and unnecessary morbidity and mortality.
He also suggested that Americans should be allowed to opt out
of Medicare, if they wish.
Speaking for the majority on the Supreme Court, Justice
Marie Deschamps said: “Courts should base their decisions on
legal principles and not on sociopolitical discourse.”
Dr. Chaoulli, 53, who was born in France and emigrated to
Quebec in 1978, says he wants to work with US entrepreneurs 
to bring about a parallel system of private healthcare in Canada.
He wants to stir a cultural revolution in the minds of Canadians
who, he believes, have for too long bought in to a Scandinavian
type of egalitarianism and statism. But, he says, “I’m not
running for political office.”
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Eighty-one percent of Americans, as well as
every major medical association, traffic safety
group and insurance company support
mandatory helmet use.  Despite this support,
in September 2003, the Pennsylvania
Legislature repealed the 35-year-old state law
mandating helmet use for all motorcyclists.
Now only those riders under age 21 are
required to wear a helmet.  Though another repeal effort failed
years earlier, the Pennsylvania Legislature voted for repeal after
extensive lobbying by a small but effective group.  
Studies show that motorcyclists are 21 times more likely to
die in a crash than are car passengers.1 According to the
National Highway Traffic Safety Administration (NHTSA),
motorcycles are only 2 percent of the registered vehicles
nationally, but motorcyclist deaths are 5 percent of traffic
fatalities annually. NHTSA also found that helmets reduce the
risk of death by 29 percent and are 67 percent effective in
preventing brain injury. While motorcycle enthusiasts disagree
with what has been published on the issue, there is compelling
evidence that helmet use reduces injury and death.  Helmeted
riders are less likely to require hospitalization, less likely to die
and less likely to suffer head and neck injuries.2,3 Maryland
repealed its helmet law in 1979; deaths and injuries climbed,
leading to reinstatement of the law in 1992.  The American
Journal of Public Health, reports motorcyclist death rates were
cut by almost 57 percent in the 33 months after the law was
reinstated.4 Helmet use decreases dramatically when states
repeal their helmet laws. Subsequently, an increase in fatalities
has been observed in every state that repealed its law.   After
Arkansas repealed its mandatory helmet law in 1997, non-
helmeted deaths at the scene of the crash increased from 39
percent to 75 percent.5 Florida estimates that the motorcycle
occupant death rate increased by nearly 49 percent in the year
following the repeal of their helmet law.6 The same expected to
happen in Pennsylvania.
Advocates of helmet repeal point to loose science to propagate
motorcycle helmet myths.  They argue that peripheral vision is
impaired — yet approved helmets must allow visibility that
exceeds normal human peripheral vision.  They argue that
helmets impair hearing — yet no study has demonstrated that
helmets reduce a driver’s ability to distinguish between sounds.
They argue that helmets increase the risk of head and neck
injuries — yet no scientifically valid study has supported this
assertion.  They argue that the chinstrap may act like a
hangman’s noose in certain crashes, injuring the rider even more
— yet no studies substantiate this claim.  Even if true, this
would be like arguing that because a seatbelt might keep a driver
from exiting a burning vehicle, a mandatory seat-belt law is bad.
One study has found no difference between helmet type (full or
partial helmet) and fastening status (loose or firmly fastened)
and cervical spine injury.7
Some bikers may argue, “It’s my head, I’ll take the risk and 
I have the right to refuse to wear a helmet.”  But the state has
clearly infringed on all of our “rights” by making it illegal to
drive without a license, to operate a vehicle while drunk, to
transport a child without a safety seat or to
exceed the speed limit. You can be ticketed in
Pennsylvania if you exercise your “right” to
drive without a seatbelt when you are
stopped for another violation.
The government is obligated to provide for
safe travel on the highway; this law is no
different.  Repeal of Pennsylvania’s helmet law will probably
cost millions in medical care, long-term rehabilitation, nursing-
home care, lost productivity, and the loss of a productive
taxpaying citizen.  Data analyzed from the National Trauma
Data Bank has shown that non-helmeted riders who are injured
accrue greater hospital charges and are significantly less likely to
have health insurance.8 The NHTSA estimates that mandatory
helmet use saved $13.2 billion between 1984 and 1999, and an
additional $11.1 billion could have been saved if all
motorcyclists wore helmets.  Already overburdened emergency
departments, hospitals, and taxpayers will absorb the cost for
uninsured motorcyclists.  If the cyclist has insurance, each
policyholder will assume some of the cost of allowing bikers to
exercise their “right” to ride without a helmet.
In my opinion, while this may look like a public policy issue
with clear and common sense answers, it is actually a civics
lesson in the legislative process.  It’s about advocacy.  Why was
helmet law repealed?  It was not repealed because to do so was 
a good idea.  It was repealed because the motorcycle lobby
advocated to their legislators better than physicians did. While a
small group of advocates were successful at bringing around the
repeal of the helmet law, these same tactics can work to reinstate
the law. Let your voice be heard. 
Motorcycle Helmets are Good Medicine
DOUGLAS MCGEE, DO, FACEP
DIRECTOR, EMERGENCY MEDICINE
RESIDENCY PROGRAM
ALBERT EINSTEIN MEDICAL CENTER
PRESIDENT, PENNSYLVANIA CHAPTER
AMERICAN COLLEGE OF
EMERGENCY PHYSICIANS
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College for Advanced
Management 
of Employee Benefits 
As reported in the December 2004
issue of the Health Policy
Newsletter, this four-day training
program is designed to improve
employers' skills in obtaining value
(improved quality and/or lower
cost) when purchasing health
benefits.  Upcoming programs 
are scheduled for:
September 19-22
Minneapolis, MN
The Health Policy Forum: 
Upcoming Speakers Fall 2005
We are pleased to announce our September – December  2005 schedule for
the Health Policy Forum. The Forum meets on the second Wednesday of each
month from 8:30 a.m. to 9:30 a.m. in Conference Room 218, Curtis Building,
1015 Walnut Street, Philadelphia, PA.  A light breakfast will be served. 
September 14, 2005
Ronald W. Swinfard, MD
Chief Medical Officer
Lehigh Valley Hospital 
and Health Network
Update on Lehigh Valley Hospital 
and Health Network
October 12, 2005
David Toub, MD, MBA
Chief Medical Officer
MedCases
Pharmaceutical Support for CME: 
A View from the Inside
November 9, 2005
Gary Rosenthal, MD
Professor and Director
Division of General Internal Medicine
University of Iowa
Certificate of Need and Specialty
Hospitals
December 14, 2005
Jeffrey P. Libson
Attorney at Law
Pepper Hamilton LLP
Intellectual Property and
Biotechnology
For more information on any of
these programs please contact
David B. Nash, MD, MBA
at (215) 955-6969 or
david.nash@jefferson.edu
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